vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $245.3M, roughly 2.0× Tecnoglass Inc.). Tecnoglass Inc. runs the higher net margin — 10.6% vs -10.1%, a 20.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 2.4%). Tecnoglass Inc. produced more free cash flow last quarter ($11.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 12.8%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.
CLOV vs TGLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $245.3M |
| Net Profit | $-49.3M | $26.1M |
| Gross Margin | — | 40.0% |
| Operating Margin | -10.1% | 18.3% |
| Net Margin | -10.1% | 10.6% |
| Revenue YoY | 44.7% | 2.4% |
| Net Profit YoY | -123.2% | -44.5% |
| EPS (diluted) | — | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $245.3M | ||
| Q3 25 | $496.6M | $260.5M | ||
| Q2 25 | $477.6M | $255.5M | ||
| Q1 25 | $462.3M | $222.3M | ||
| Q4 24 | $337.0M | $239.6M | ||
| Q3 24 | $331.0M | $238.3M | ||
| Q2 24 | $356.3M | $219.7M | ||
| Q1 24 | $346.9M | $192.6M |
| Q4 25 | $-49.3M | $26.1M | ||
| Q3 25 | $-24.4M | $47.2M | ||
| Q2 25 | $-10.6M | $44.1M | ||
| Q1 25 | $-1.3M | $42.2M | ||
| Q4 24 | $-22.1M | $47.0M | ||
| Q3 24 | $-9.2M | $49.5M | ||
| Q2 24 | $7.4M | $35.0M | ||
| Q1 24 | $-19.2M | $29.7M |
| Q4 25 | — | 40.0% | ||
| Q3 25 | — | 42.7% | ||
| Q2 25 | — | 44.7% | ||
| Q1 25 | — | 43.9% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | 24.5% | 45.8% | ||
| Q2 24 | 30.3% | 40.8% | ||
| Q1 24 | 23.6% | 38.8% |
| Q4 25 | -10.1% | 18.3% | ||
| Q3 25 | -4.9% | 25.1% | ||
| Q2 25 | -2.2% | 24.0% | ||
| Q1 25 | -0.3% | 26.7% | ||
| Q4 24 | -6.4% | 28.0% | ||
| Q3 24 | -2.7% | 28.4% | ||
| Q2 24 | 2.0% | 23.3% | ||
| Q1 24 | -6.5% | 21.3% |
| Q4 25 | -10.1% | 10.6% | ||
| Q3 25 | -4.9% | 18.1% | ||
| Q2 25 | -2.2% | 17.3% | ||
| Q1 25 | -0.3% | 19.0% | ||
| Q4 24 | -6.6% | 19.6% | ||
| Q3 24 | -2.8% | 20.8% | ||
| Q2 24 | 2.1% | 15.9% | ||
| Q1 24 | -5.5% | 15.4% |
| Q4 25 | — | $0.57 | ||
| Q3 25 | — | $1.01 | ||
| Q2 25 | — | $0.94 | ||
| Q1 25 | — | $0.90 | ||
| Q4 24 | — | $1.00 | ||
| Q3 24 | — | $1.05 | ||
| Q2 24 | — | $0.75 | ||
| Q1 24 | — | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $104.1M |
| Total DebtLower is stronger | — | $174.4M |
| Stockholders' EquityBook value | $308.7M | $713.1M |
| Total Assets | $541.0M | $1.3B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $104.1M | ||
| Q3 25 | — | $127.1M | ||
| Q2 25 | — | $140.9M | ||
| Q1 25 | — | $160.2M | ||
| Q4 24 | $194.5M | $137.5M | ||
| Q3 24 | $288.0M | $124.8M | ||
| Q2 24 | $254.8M | $129.5M | ||
| Q1 24 | $208.3M | $138.8M |
| Q4 25 | — | $174.4M | ||
| Q3 25 | — | $114.7M | ||
| Q2 25 | — | $110.6M | ||
| Q1 25 | — | $110.6M | ||
| Q4 24 | — | $111.1M | ||
| Q3 24 | — | $126.8M | ||
| Q2 24 | — | $144.7M | ||
| Q1 24 | — | $160.9M |
| Q4 25 | $308.7M | $713.1M | ||
| Q3 25 | $340.9M | $764.0M | ||
| Q2 25 | $344.2M | $736.0M | ||
| Q1 25 | $336.1M | $685.1M | ||
| Q4 24 | $341.1M | $631.2M | ||
| Q3 24 | $342.2M | $613.3M | ||
| Q2 24 | $324.9M | $574.8M | ||
| Q1 24 | $292.5M | $573.6M |
| Q4 25 | $541.0M | $1.3B | ||
| Q3 25 | $559.7M | $1.2B | ||
| Q2 25 | $575.0M | $1.2B | ||
| Q1 25 | $583.7M | $1.1B | ||
| Q4 24 | $580.7M | $1.0B | ||
| Q3 24 | $653.0M | $996.3M | ||
| Q2 24 | $674.2M | $942.5M | ||
| Q1 24 | $671.8M | $981.6M |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.25× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $31.0M |
| Free Cash FlowOCF − Capex | $-69.0M | $11.4M |
| FCF MarginFCF / Revenue | -14.1% | 4.7% |
| Capex IntensityCapex / Revenue | 0.4% | 8.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $31.0M | ||
| Q3 25 | $12.1M | $40.0M | ||
| Q2 25 | $5.4M | $17.9M | ||
| Q1 25 | $-16.3M | $46.9M | ||
| Q4 24 | $34.8M | $61.1M | ||
| Q3 24 | $50.0M | $41.5M | ||
| Q2 24 | $44.8M | $34.5M | ||
| Q1 24 | $25.9M | $33.4M |
| Q4 25 | $-69.0M | $11.4M | ||
| Q3 25 | $11.4M | $21.2M | ||
| Q2 25 | $4.8M | $-14.7M | ||
| Q1 25 | $-16.5M | $16.5M | ||
| Q4 24 | $33.3M | $35.4M | ||
| Q3 24 | $49.6M | $17.8M | ||
| Q2 24 | $44.4M | $14.2M | ||
| Q1 24 | $25.5M | $23.6M |
| Q4 25 | -14.1% | 4.7% | ||
| Q3 25 | 2.3% | 8.2% | ||
| Q2 25 | 1.0% | -5.7% | ||
| Q1 25 | -3.6% | 7.4% | ||
| Q4 24 | 9.9% | 14.8% | ||
| Q3 24 | 15.0% | 7.5% | ||
| Q2 24 | 12.5% | 6.5% | ||
| Q1 24 | 7.3% | 12.2% |
| Q4 25 | 0.4% | 8.0% | ||
| Q3 25 | 0.1% | 7.2% | ||
| Q2 25 | 0.1% | 12.7% | ||
| Q1 25 | 0.0% | 13.7% | ||
| Q4 24 | 0.5% | 10.7% | ||
| Q3 24 | 0.1% | 9.9% | ||
| Q2 24 | 0.1% | 9.2% | ||
| Q1 24 | 0.1% | 5.1% |
| Q4 25 | — | 1.19× | ||
| Q3 25 | — | 0.85× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | 6.04× | 0.98× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
TGLS
| Product Sales | $164.2M | 67% |
| Fixed Price Contracts | $81.1M | 33% |
| Related Party | $692.0K | 0% |
